Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Adhoute

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|February 14, 2015
Reply to: ''Repeated transarterial chemoembolization: An overfitting effort?''Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Journal of Hepatology|February 26, 2016
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2017
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
World Journal of Hepatology|January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinomaJean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Journal of Hepatology|September 19, 2017
Response to 'the flexible therapeutic approach to the BCLC B stage': Time for scoring systems?Xavier Adhoute, Guillaume Pénaranda, Floriane Sellier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 31, 2016
Nomogram of the Barcelona Clinic Liver Cancer System: external validation in European patientsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Journal of Nuclear Medicine Technology|September 1, 2011
Is liver SUV stable over time in ¹⁸F-FDG PET imaging?Eric Laffon, Xavier Adhoute, Henri de Clermont, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 11, 2016
HCC classification and HCC scoring system: a win-win combination for prognosis and treatment recommendationsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 28, 2017
Intermediate stage treatment: Is TACE enough?Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Expert Opinion on Pharmacotherapy|September 13, 2017
An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinomaJean-Luc Raoul, Marine Gilabert, Xavier Adhoute, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|February 14, 2015
Reply to: ''Repeated transarterial chemoembolization: An overfitting effort?''Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Journal of Hepatology|February 26, 2016
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2017
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
World Journal of Hepatology|January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinomaJean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Journal of Hepatology|September 19, 2017
Response to 'the flexible therapeutic approach to the BCLC B stage': Time for scoring systems?Xavier Adhoute, Guillaume Pénaranda, Floriane Sellier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 31, 2016
Nomogram of the Barcelona Clinic Liver Cancer System: external validation in European patientsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Journal of Nuclear Medicine Technology|September 1, 2011
Is liver SUV stable over time in ¹⁸F-FDG PET imaging?Eric Laffon, Xavier Adhoute, Henri de Clermont, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 11, 2016
HCC classification and HCC scoring system: a win-win combination for prognosis and treatment recommendationsXavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 28, 2017
Intermediate stage treatment: Is TACE enough?Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Expert Opinion on Pharmacotherapy|September 13, 2017
An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinomaJean-Luc Raoul, Marine Gilabert, Xavier Adhoute, et al.
Pageof 7